Advanced search

Report side effect

Report a suspected side effect or falsified product to the MHRA Yellow Card scheme.
Go to {yellow_card_logo} site
{arrow_up} Back to top

VYEPTI 100 mg concentrate for solution for infusion {equilateral_black_triangle}

Active Ingredient:
eptinezumab
Company:  
Lundbeck Limited See contact details
ATC code: 
N02CD05
{info_black}
About Medicine
{medical_services}
Prescription only medicine
Healthcare Professionals (SmPC) Patient Leaflet (PIL) HCP Med Info
{arrow_left}
{arrow_right}
The Patient Information Leaflet (PIL) is the leaflet included in the pack with a medicine.
{info_black}
Last updated on emc: 10 Apr 2024

{equilateral_black_triangle} This medicinal product is subject to additional monitoring. This will allow quick identification of new safety information.

{pdf} View or print the patient leaflet as PDF
Lundbeck Limited
Company image
Address
Iveco House , Station Road, Watford, Hertfordshire, WD17 1ET, UK
WWW
http://www.lundbeck.co.uk
Telephone
+44 (0)1908 649 966
Medical Information Direct Line
+44 (0)1908 638 972
Medical Information e-mail
[email protected]
Customer Care direct line
+44 (0)1908 649966